ESC Premium Access

Discovery and replication of new risk markers for 5-year kidney function decline using a targeted multiplex proteomics chip

Congress Presentation

About the speaker

Professor Johan Arnlov

Uppsala (Sweden)
0 follower

18 more presentations in this session

Similar high distance to recommended LDL-cholesterol-targets despite chronic statin treatment in Europe, Canada, Middle East, Africa and Asia - Results of DYSIS

Speaker: Doctor A. Gitt (Ludwigshafen, DE)


Prevalence of elevated LDL- cholesterol and the risk of cardiovascular events in a population with established atherosclerotic cardiovascular disease, type 2 diabetes and metabolic dyslipidemia

Speaker: Doctor J. Rana (Oakland, US)


Trends in high-intensity statin therapy after myocardial infarction, 2011-2014

Speaker: Professor R. Rosenson (New York, US)


Cardiovascular events of patients presenting with peripheral artery disease (PAD): an epidemiological analysis using a claims database in France

Speaker: Professor A. Bura Riviere (Toulouse, FR)


Impact of cardiovascular co-morbidities on all-cause mortality in lung, breast, prostate and bowel cancer

Speaker: Doctor P. Carter (Cambridge, GB)


Access the full session

Poster session 2 - Cardiovascular risk in populations

Speakers: Professor J. Arnlov, Doctor A. Gitt, Doctor J. Rana, Professor R. Rosenson, Professor A. Bura Riviere...

About the event



27 August - 31 August 2016

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk